OBJECTIVES C1q / TNF-related protein (CTRP) 9, as an adiponectin paralog, is an adipocytokine that play an important role in glucose and lipid metabolism. ET-1 has been shown to induce insulin resistance in vitro and in vivo and proposed that it might regulate adiponectin expression. In the present study, we explored the regulatory effects of ET-1 on CTRP 9 gene expression and the underlying mechanisms in hypertrophic cardiomyocytes.
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Endothelin-1 Upregulates CTRP9 Gene Expression in Cardiomyocytes Bingyan Guo, Yongjun Li The Second Hospital of Hebei Medical University OBJECTIVES C1q / TNF-related protein (CTRP) 9, as an adiponectin paralog, is an adipocytokine that play an important role in glucose and lipid metabolism. ET-1 has been shown to induce insulin resistance in vitro and in vivo and proposed that it might regulate adiponectin expression. In the present study, we explored the regulatory effects of ET-1 on CTRP 9 gene expression and the underlying mechanisms in hypertrophic cardiomyocytes.
METHODS Neonatal rat ventricular myocytes (NRVMs) were treated with various concentrations of ET-1, and CTRP9 gene expression was measured by quantitative real-time reverse transcription-polymerase chain reaction.
RESULTS ET-1 was found to cause a significant time-and dosedependent increase in CTRP 9 gene expression, and this effect was inhibited by the ET type A receptor (ETAR) antagonist BQ-610 but not by the ETBR antagonist BQ-788. To explore the underlying mechanism, we examined the involvement of the cAMP-dependent protein kinase A-, phospholipase A2-, protein kinase C-, and MAPK mediated pathways using inhibitors and found that only PD98059 and U0126, inhibitors that blocked MAPK/ERK kinase's ability to activate the ERKs, prevented ET-1-induced up-regulation of CTRP 9.
CONCLUSIONS These data suggest a mechanism whereby ET-1 upregulates CTRP 9 gene expression in NRVMs via the ET type A receptor/ MAPK/ERK signaling pathway.
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Constitutive Expression of IGF-1 in BMSCs Improves Migration, Attenuates Cardiomyocyte Apoptosis and Promotes Cardiac Function After Acute Myocardial Infarction in Rats.
Jia Xu, Ren Jiang, Hong Zhan, Ruibin Cai, Zi Ye, Yan Xiong 1 st affiliated hospital of Sun Yat-sen University OBJECTIVES In this study, we explored the potential role of intramyocardial BMSCs-IGF-1 transplanation in reducing cardiomyocyte apoptosis,mediating cell migration and restoring myocardial function.
METHODS BMSCs were lentivirally transduced to express stable forms of IGF-1. AMI model was induced by ligation of left main coronary artery in female Sprague-Dawley rats. Experimental rats were randomized into 3 groups: AMI (group control),BMSCs transplantation (group M), BMSCs-IGF-1 transplanation (group IGF-1-M). BMSCs and BMSCs-IGF-1 were injected via cauda vein in recipient rats 3 and 7days after MI,the EGFP donor cells were traced in MSCs recipient rats by fluorescence microscopy. VEGF and CXCR4 mRNA and protein expression in the region bordering an infarct were determined by means of RT-PCR and western blot analysis. HE staining and TUNEL were performed to assess pathological changes and cardiomyocyte apoptosis and proliferation, respectively. LV function was evaluated using echocardiography. RESULTS Significant improvement of myocardial deficits was found in BMSCs-IGF-1-transplanted rats compared with control animals at 3 days and 7 days after AMI. Histological evaluation showed that BMSCs-IGF-1 transplantation significantly promoted cardiomyocyte survival and attenuated neuronal apoptosis in the ischemic boundary area especially at 7 day. VEGF and CXCR4 were upregulated at mRNA and protein levels in IGF-1-modified BMSCs. On the other hand, MIdilated impaired LV function with reduced fractional shortening, cardiomyocyte peak shortening and relengthening were improved by BMSCs-IGF-1 therapy which were superior to BM-MSCs and control group at both of 3 and 7 days.
CONCLUSIONS Intra-myocardial delivery of BMSCs-IGF-1 could selectedly migrate to peri-infarct area, activated transcription genes, attenuated MI-induced apoptosis, and restored LV function. Taken together, transplantation of BMSCs-IGF-1 represent a new strategy to improve cardiac function after MI superior to bone marrow MSCs with higher security and efficiency.
GW26-e5322 Downregulation of MicroRNA-17 Improves Cardiac Function After Myocardial Infarction Via Attenuation of Apoptosis in Endothelial Cells
Shuo Yang, Jing Chen, Qi Hu, Changwu Xu, Hong Jiang Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China OBJECTIVES Impairment of microcirculation is one of the major reasons for the aggravation of cardiac function after myocardial infarction (MI). Studies have indicated that microRNA -17 (miR-17) has the ability to inhibit angiopoiesis in tumors. Here we hypothesized that downregulation of miR-17 might enhance cardiac function after MI though improving endothelial function and increasing the density of new blood vessels after MI.
METHODS Human umbilical vein endothelial cells (HUVECs) were infected with adenovirus containing pre-mir-17,antagomir-17 or control adenovirus (Ad(N)) for miR-17 over expression (Ad-Pre-miR-17) or miR-17 silencing (Ad-Antagomir-17). Apoptosis was induced and determined by Annexin V-7ADD/PI. Real time RTPCR was used to evaluate levels of miR-17 and ERK. Protein levels of ERK and apoptosis proteins including bcl2,bax,caspas3 and caspas9 were determined by western blot In vivo, MI model was established in SD male rats. Adenoviruses (5*109/100ml) mentioned above were injected into the apex of heart. Cadiac function was evaluated by echocardiography before models were built, and reevaluated at 7 days or 28 days after MI. Followed with echocardiography cardiac tissue of infarction border area was removed for histological examination, real time RT-PCR and western blot, as described above.
RESULTS MiR-17 level was down regulated by 23% in Ad-Antagomir-17 group, but up regulated 2.7-fold in Ad-Pre-miR-17 group (p <0.05). ERK pathway could be stimulated by miR-17 silencing, which demonstrated increased levels of phosphorylated ERK(P-ERK) and anti-apoptosis protein bcl-2 1.42-fold and 1.40-fold. However, apoptosis proteins, including bax,caspas3, caspas9 were decreased by 23.1%,29.2%,33%,respectively(p<0.05) in Ad-Antagomir-17 group. In Ad-pre-mir-17group,PERK and bcl-2 were down regulated by 11.4% and 69.8%,while apoptosis proteins mentioned above were up regulated by 2.05-fold, 1.35-fold, 2.04-fold, respectively (p<0.05) MiR-17 level was decreased by 9.7%and 41.2%, respectively, in hearts from rats in Ad-Antagomir-17 group after MI was established for 7 days or 28 days (p<0.05). Echocardiography revealed that down regulation of miR-17 enhanced the heart ejection fraction(EF) by 2.18-fold at 7 days, and 2.24-fold at 28 days (p<0.05). After 7day MI or 28day MI, histological examination showed that infarction areas and collagen fiber were decreased by 43.7% and 73.2%, 53.3% and 61.1%, CONCLUSIONS Apoptosis in ECs could be inhibited by down regulation of miR17 though ERK pathway. Down regulation of microRNA17 could improve cardiac function after myocardial infarction via attenuation of apoptosis in endothelial cells. OBJECTIVES Curcumin, the active ingredient in curcuma rhizomes, has a wide range of therapeutic effects. However, its atheroprotective activity in human acute monocytic leukemia THP-1 cells remains unclear. We investigated the activity and molecular mechanism of action of curcumin in polarized macrophages. 
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